Horizon Kinetics Medical ETFMEDXETF

13F holders, Q3 2025 (September 30)
4holders −1
0new positions
1sold out
$29.89avg. 13F price*

At the end of Q3 2025, 4 institutions reported holding Horizon Kinetics Medical ETF (MEDX) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holders were UBS Group AG ($53K), HighMark Wealth Management LLC ($5K) and FMR LLC ($239).

Company
Horizon Kinetics Medical ETF
Filed as
LISTED FDS TR (Q3 2025)
CUSIP
53656G563
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 4Q1 2024Q2 2024: 3Q2 2024Q3 2024: 4Q3 2024Q4 2024: 7Q4 2024Q1 2025: 4Q1 2025Q2 2025: 5Q2 2025Q3 2025: 4Q3 2025Q4 2025: 5Q4 2025Q1 2026: 6Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits1$20K

All 13F filers, Q2 2025 → Q3 2025: 1,183 shares sold, net −1,183 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

UBS Group AG 0.00% Reduce -19.0% 1,783 $53K
HighMark Wealth Management LLC 0.00% No change 165 $5K
FMR LLC 0.00% No change 8 $239
Wells Fargo & Company 0.00% No change 1 $23

"% of holder's portfolio" is MEDX's weight in each manager's 13F, not the share of Horizon Kinetics Medical ETF the manager owns.